Zai Lab Ltd at Citi BioPharma Conference Transcript

Sep 08, 2022 / 12:50PM GMT
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director

Everyone, mainly the people on the webcast, but okay. It's a great pleasure to have senior management from Zai Lab here. I've been following Zai Lab since they were a private company back in 2017. In fact, I've been to China a few times to see their operations. So I want to welcome Billy Cho, CFO; Josh Smiley, COO, who just recently joined the company officially, I think August 1.

Joshua L. Smiley - Zai Lab Limited - COO

That's right. Yes.

Questions and Answers:

Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director

So welcome both of you. I guess at a high level, I think we can just start by a broad strategy question. What is Zai's mission? How are you different from some of your key competitors in the China biotech space? And what's the core investment case for Zai Lab?

Joshua L. Smiley - Zai Lab Limited - COO

Sure. No, thanks, Yigal, and thanks for having us. I think it's pretty
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot